These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1581892)

  • 21. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.
    Vanhoefer U; Cao S; Minderman H; Toth K; Skenderis BS; Slovak ML; Rustum YM
    Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines.
    Nakanishi O; Baba M; Saito A; Yamashita T; Sato W; Abe H; Fukazawa N; Suzuki T; Sato S; Naito M; Tsuruo T
    Oncol Res; 1997; 9(2):61-9. PubMed ID: 9167187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
    Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of modifiers of multiple drug resistance to overcome tumor resistance to cytostatics in an in vivo system].
    Sitdikova SM; Donenko FV; Kabieva AO; Polotskiĭ BE; Moroz LV
    Biull Eksp Biol Med; 1996 Apr; 121(4):459-61. PubMed ID: 8829468
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sufficient levels of quinine in the serum circumvent the multidrug resistance of the human leukemic cell line K562/ADM.
    Solary E; Velay I; Chauffert B; Bidan JM; Caillot D; Dumas M; Guy H
    Cancer; 1991 Oct; 68(8):1714-9. PubMed ID: 1913513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of a combination of three cinchona bark alkaloids against Plasmodium falciparum in vitro.
    Druilhe P; Brandicourt O; Chongsuphajaisiddhi T; Berthe J
    Antimicrob Agents Chemother; 1988 Feb; 32(2):250-4. PubMed ID: 3284455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-benzyladriamycin-14-valerate (AD 198)-resistant cells exhibit highly selective cross-resistance to other anthracyclines that circumvent multidrug resistance.
    Lothstein L; Hosey LM; Sweatman TW; Koseki Y; Dockter M; Priebe W
    Oncol Res; 1993; 5(6-7):229-34. PubMed ID: 7907237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the antimalarial activity of the cinchona alkaloids against Plasmodium falciparum in vitro.
    Wesche DL; Black J
    J Trop Med Hyg; 1990 Jun; 93(3):153-9. PubMed ID: 2190002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
    Peer D; Dekel Y; Melikhov D; Margalit R
    Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
    Mankhetkorn S; Dubru F; Hesschenbrouck J; Fiallo M; Garnier-Suillerot A
    Mol Pharmacol; 1996 Mar; 49(3):532-9. PubMed ID: 8643093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms.
    Wu W; Luo Y; Sun C; Liu Y; Kuo P; Varga J; Xiang R; Reisfeld R; Janda KD; Edgington TS; Liu C
    Cancer Res; 2006 Jan; 66(2):970-80. PubMed ID: 16424032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
    Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM
    Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma].
    Zhu L; Lang J; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):462-6. PubMed ID: 9639738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxazolinodoxorubicin - a promising new anthracycline.
    Lukawska M; Klopotowska D; Milczarek M; Wietrzyk J; Studzian K; Szmigiero L; Porebska A; Oszczapowicz I
    Anticancer Res; 2012 Jul; 32(7):2959-65. PubMed ID: 22753760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of quinine and cinchonine on human neutrophils functions in vitro.
    el Benna J; Labro MT
    J Antimicrob Chemother; 1990 Jun; 25(6):949-57. PubMed ID: 2164514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes.
    Solary E; Mannone L; Moreau D; Caillot D; Casasnovas RO; Guy H; Grandjean M; Wolf JE; André F; Fenaux P; Canal P; Chauffert B; Wotawa A; Bayssas M; Genne P
    Leukemia; 2000 Dec; 14(12):2085-94. PubMed ID: 11187897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cinchonine, a Cinchona bark alkaloid, on spontaneous and induced rat ileum contractions.
    Rankovic G; Stankovic V; Zivkovic M; Rankovic B; Laketic D; Potic M; Saranovic M; Rankovic GN
    Bratisl Lek Listy; 2019; 120(8):576-580. PubMed ID: 31379180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of idarubicin in the isolated perfused rat lung: effect of cinchonine and rutin.
    Kuhlmann O; Hofmann HS; Müller SP; Weiss M
    Anticancer Drugs; 2003 Jul; 14(6):411-6. PubMed ID: 12853881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.